Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Van Peer

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Acta Anaesthesiologica Belgica|January 1, 1984
Overview of the clinical pharmacokinetics of alfentanilA Van Peer, J C Levron, H Noorduin, et al.
Archives of Disease in Childhood|April 1, 1990
Alfentanil pharmacokinetics in preterm infantsN Marlow, A M Weindling, A Van Peer, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1993
Pharmacokinetic-pharmacodynamic relationships in phase I/phase II of drug developmentA Van Peer, E Snoeck, M L Huang, et al.
Journal of Pharmaceutical Sciences|April 1, 1982
Properties, stability, assay, and preliminary pharmacokinetics of the immunomodulatory 1,2-O-isopropylidene-3-O-3'(N',N'-dimethylamino-n-propyl)-D-glucofuranose hydrochlorideE R Garrett, A Van Peer, H Mahrous, et al.
Therapeutic Drug Monitoring|January 1, 1989
Cisapride-cimetidine interaction: enhanced cisapride bioavailability and accelerated cimetidine absorptionW Kirch, H D Janisch, E E Ohnhaus, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Alfentanil kinetics in renal insufficiencyA Van Peer, M Vercauteren, H Noorduin, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administrationJ Heykants, A Van Peer, R Woestenborghs, et al.
British Journal of Clinical Pharmacology|December 14, 1999
Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux diseaseY Preechagoon, B Charles, V Piotrovskij, et al.
Clinical Pharmacology and Therapeutics|August 1, 1984
Alfentanil kinetics in the elderlyH Helmers, A Van Peer, R Woestenborghs, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patientsV K Piotrovsky, M L Huang, A Van Peer, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Acta Anaesthesiologica Belgica|January 1, 1984
Overview of the clinical pharmacokinetics of alfentanilA Van Peer, J C Levron, H Noorduin, et al.
Archives of Disease in Childhood|April 1, 1990
Alfentanil pharmacokinetics in preterm infantsN Marlow, A M Weindling, A Van Peer, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1993
Pharmacokinetic-pharmacodynamic relationships in phase I/phase II of drug developmentA Van Peer, E Snoeck, M L Huang, et al.
Journal of Pharmaceutical Sciences|April 1, 1982
Properties, stability, assay, and preliminary pharmacokinetics of the immunomodulatory 1,2-O-isopropylidene-3-O-3'(N',N'-dimethylamino-n-propyl)-D-glucofuranose hydrochlorideE R Garrett, A Van Peer, H Mahrous, et al.
Therapeutic Drug Monitoring|January 1, 1989
Cisapride-cimetidine interaction: enhanced cisapride bioavailability and accelerated cimetidine absorptionW Kirch, H D Janisch, E E Ohnhaus, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Alfentanil kinetics in renal insufficiencyA Van Peer, M Vercauteren, H Noorduin, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administrationJ Heykants, A Van Peer, R Woestenborghs, et al.
British Journal of Clinical Pharmacology|December 14, 1999
Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux diseaseY Preechagoon, B Charles, V Piotrovskij, et al.
Clinical Pharmacology and Therapeutics|August 1, 1984
Alfentanil kinetics in the elderlyH Helmers, A Van Peer, R Woestenborghs, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patientsV K Piotrovsky, M L Huang, A Van Peer, et al.
Pageof 7